Jane Street’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$937K Buy
304,300
+144,500
+90% +$614K ﹤0.01% 6653
2025
Q4
$577K Buy
159,800
+91,100
+133% +$397K ﹤0.01% 7369
2025
Q3
$259K Sell
68,700
-26,700
-28% -$103K ﹤0.01% 9200
2025
Q2
$369K Buy
95,400
+47,000
+97% +$254K ﹤0.01% 7479
2025
Q1
$242K Sell
48,400
-66,400
-58% -$421K ﹤0.01% 8163
2024
Q4
$828K Buy
114,800
+74,600
+186% +$570K ﹤0.01% 5741
2024
Q3
$247K Sell
40,200
-170,200
-81% -$1.15M ﹤0.01% 8344
2024
Q2
$1.4M Sell
210,400
-21,000
-9% -$155K ﹤0.01% 5127
2024
Q1
$2.36M Sell
231,400
-63,900
-22% -$650K ﹤0.01% 3836
2023
Q4
$3.32M Buy
+295,300
New +$1.23M ﹤0.01% 3472
2023
Q3
Sell
-12,500
Closed -$44.1K 8555
2023
Q2
$44.1K Sell
12,500
-355,200
-97% -$1.59M ﹤0.01% 8237
2023
Q1
$1.55M Buy
367,700
+289,900
+373% +$3.44M ﹤0.01% 4254
2022
Q4
$1.28M Sell
77,800
-121,800
-61% -$1.37M ﹤0.01% 4588
2022
Q3
$2.55M Buy
199,600
+150,400
+306% +$2.22M ﹤0.01% 3755
2022
Q2
$576K Buy
49,200
+26,000
+112% +$160K ﹤0.01% 6479
2022
Q1
$141K Sell
23,200
-67,200
-74% -$495K ﹤0.01% 9273
2021
Q4
$828K Sell
90,400
-99,900
-52% -$1.06M ﹤0.01% 6284
2021
Q3
$2.15M Buy
190,300
+78,400
+70% +$953K ﹤0.01% 4333
2021
Q2
$1.1M Buy
111,900
+6,800
+6% +$93K ﹤0.01% 5623
2021
Q1
$1.49M Buy
105,100
+7,900
+8% +$128K ﹤0.01% 4628
2020
Q4
$1.1M Buy
97,200
+12,100
+14% +$143K ﹤0.01% 4500
2020
Q3
$1.12M Buy
85,100
+38,600
+83% +$772K ﹤0.01% 3907
2020
Q2
$498K Buy
+46,500
New +$255K ﹤0.01% 5088

Other funds holding ALT

Jane Street's ALT Position: Q1 2026 in Review

Jane Street sold out of Altimmune (ALT) in Q1 2026, closing a stake of 1,783,950 shares — an estimated $7.57M sold.

Jane Street first reported a position in ALT in Q2 2013 and held it in 22 quarters. The position peaked at $6.53M in Q4 2023. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Jane Street reported no remaining Altimmune position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 1,783,950 Altimmune shares in Q1 2026, an estimated $7.57M.
  • Jane Street first reported a position in Altimmune in Q2 2013 and held it in 22 quarters.
  • Jane Street's Altimmune position peaked at $6.53M in Q4 2023.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.